Mixed Mode Chromatography Resin for Antibody Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for extracting and purifying immunoglobulins and other proteins from biological samples are inefficient in separating monomeric antibodies from antibody aggregates, leading to impurities in diagnostic and therapeutic applications.

Innovation Solution

Development of chromatography resins with anionic exchange-hydrophobic mixed mode ligands, specifically designed to efficiently purify target biomolecules by separating monomeric antibodies from aggregates through bind-elute or flow-through modes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If current extraction and purification methods are used, then the process is simple, but the separation efficiency of monomeric antibodies from aggregates is insufficient

Engineering Contradiction:
Improveseparation efficiencyVSAvoidchromatography resin structure
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies composite materials by creating a chromatography resin with dual functional ligands that combine anionic exchange and hydrophobic interaction properties. The resin matrix is functionalized with ligands containing both charged groups (for ionic interactions) and hydrophobic aromatic groups (for hydrophobic interactions), enabling simultaneous exploitation of multiple binding mechanisms to achieve superior separation of monomeric antibodies from aggregates compared to conventional single-mode resins

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent implements local quality by designing ligands with specific spatial arrangements where aromatic hydrophobic groups and charged anionic exchange groups are positioned at different locations on the ligand structure. This localized functional differentiation allows the resin to provide distinct interaction zones: hydrophobic regions for capturing aggregate structures and charged regions for ionic interactions with antibody surfaces, thereby enhancing separation selectivity

Inventive Principle:
Principle #3Local quality

2Manufacturing precision

If conventional chromatography resins are used, then the operation is straightforward, but the purity of monomeric antibodies obtained is insufficient

Engineering Contradiction:
Improvepurification purityVSAvoidligand structure
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent employs composite materials by synthesizing ligands that integrate both anionic exchange functional groups (such as carboxylates or sulfonates) and hydrophobic aromatic moieties (such as phenyl or naphthyl groups) into a single chromatography resin structure. This composite ligand design enables dual-mode binding mechanisms that work synergistically to achieve high purity separation of monomeric antibodies from aggregates, outperforming conventional single-function resins

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent applies parameter changes by modifying the chemical structure of chromatography ligands to include both charged and hydrophobic characteristics. The ligands are designed with specific parameters: aromatic rings providing hydrophobic surface area and charged groups providing ionic interaction capability. These structural parameter modifications enable the resin to selectively bind aggregates through combined hydrophobic and ionic interactions while allowing monomeric antibodies to pass through or bind with different affinity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The chromatography resins effectively purify monomeric antibodies by immobilizing aggregates, resulting in high purity and yield of monomeric antibodies, suitable for diagnostic and therapeutic uses.

Implementation Method 1

Chromatography resins comprising chromatography matrices linked to an anionic exchange-hydrophobic mixed mode ligand

Methodology Applied
Scientific EffectAnionic exchange: Ion Exchange

Implementation Method 2

an anionic exchange-hydrophobic mixed mode ligand

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 3

The chromatography resins effectively purify monomeric antibodies by immobilizing aggregates

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS20250144597A1Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand
Publication Date: 2025.05.08 BIO RAD LABORATORIES INC
  • US20250144597A1 patent drawing
  • US20250144597A1 patent drawing
  • US20250144597A1 patent drawing

AI summary

Chromatography resins having mixed mode ligands and methods of using such resins are provided.